Evaluation of chemotherapy in bladder cancer
Author(s)
Bibliographic Information
Evaluation of chemotherapy in bladder cancer
(Societe internationale d'urologie reports)
Churchill Livingstone, 1992
Available at 8 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes Index
Description and Table of Contents
Description
In November 1991 the Societe International d'Urologie (SIU) held it 22nd congress in Seville and five reports, based on papers and discussions at key sessions, will be published at intervals, in Autumn 1992. "Evaluation of Chemotherapy for Bladder Cancer" aims to provide state-of-the-art coverage of this topic, with contributions from international specialists. This book should enable the practising urologist to keep completely up to date in this fast-moving area of urology, with important new developments covered, and in-depth analysis of current trends. Other titles in the series include: "Non-Surgical Treatment of BPH"; "Continent Urinary Diversion"; "Oncogenes and Molecular Genetics of Urological Tumours"; and "Urinary Incontinence".
Table of Contents
- The evaluation of prophylactic intravescial chemotherapy for superficial bladder cancer
- treatment of TIS of the urinary bladder - first results of protocol of the EORTC protocol 30861
- interferon alfa-AB 60 million vs 100 millions in intravesical prophylaxis of superficial bladder cancer
- long-term follow-up of camptothecin instillation for prevention and treatment of urinary bladder tumors
- the fate of G3 pTI bladder cancer - progression, recurrence and survival
- whole layer needle biopsy to evaluate neoadjuvant therapy in invasive bladder cancer
- laparoscopic lymphadenectomy - a new option for staging in bladder cancer
- radical TUR and chemotherapy aiming at bladder preservation
- BHCG and bladder cancer
- the Cueto prospective study 84005 on neoadjuvant cisplatinum before radical cystectomy - survival at 3.5 years
- progress report on the overview of two randomized trials of cisplatinum in invasive transitional cell carcinoma of the bladder
- preliminary analysis of a random study of neoadjuvant chemotherapy plus cystectomy versus cystectomy in patients with invasive bladder carcinoma
- EORTC studies on first-line chemotherapy in invasive bladder cancer
- chemotherapy for advanced bladder cancer - three kinds of regimes (MVAC, CAP and CAF)
- role of chemo-Rx-therapy
- neoadjuvant chemo and radiotherapy versus radiotherapy as precystectomy treatment in bladder cancer
- is pelvis lymphadenectomy curative for N1 bladder tumors?
- histological interpretation of the post chemotherapy urinary bladder cancer
- chemotherapy in metastatic disease.
by "Nielsen BookData"